BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Apricus Biosciences, Stellar Pharmaceuticals Inc. Sign MycoVa License Agreement in Canada

  January 3, 2012

   · 

  9 min read
• Biotech Beach

  Edwards Lifesciences Corporation to Present at the 30th Annual J.P. Morgan Healthcare Conference

  January 3, 2012

   · 

  1 min read
• Policy

  Amgen Release: FDA to Review Potential New Use of XGEVA(R) (Denosumab) at Oncologic Drugs Advisory Committee Meeting

  January 3, 2012

   · 

  11 min read
• The Native Antigen Company Ltd Release: New - Highly Purified, Cost-Effective CMV Native Antigen for IgM

  January 3, 2012

   · 

  1 min read
• Pharm Country

  Olympus America Offers TissuemorphDP™ Cell Analysis Software Module from Visiopharm

  January 3, 2012

   · 

  2 min read
• Golden Meditech Further Repurchases Shares

  January 3, 2012

   · 

  1 min read
• Biotech Beach

  Critical Diagnostics Release: Presage® ST2 Assay Enters Routine Use for Heart Failure Patient Care

  January 3, 2012

   · 

  1 min read
• Pharm Country

  Ossianix Announces Lundbeck Inc. Investment

  January 3, 2012

   · 

  1 min read
• Business

  Vexim, the Specialist in Minimally Invasive Anatomical Restoration of Vertebral Compression Fractures, Reinforces its Management Team in Order to Accelerate the Commercial Deployment of the SpineJack®

  January 3, 2012

   · 

  1 min read
• Artimplant Invests in Expanded Own Sales

  January 3, 2012

   · 

  1 min read